Amphastar Pharmaceuticals AMPH
$28.25 +$0.14 (+0.50%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.26 +0.04%
Open$28.14
Prev close$28.11
Day range$27.79 – $28.70
Volume498.5K
Market cap$1.20B
P/E (TTM)13.0
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$207.61M+8.2% YoY
Operating profit$50.77M+100.5% YoY
Net profit$37.76M+117.7% YoY
Diluted EPS$0.87+135.1% YoY
Free cash flow-$61.14M-229.4% YoY
Operating cash flow$43.30M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin46.8%
Operating margin18.7%
Net margin13.3%
Return on equity12.4%
Return on assets5.9%
Return on invested capital7.6%
Current ratio3.32
Liabilities / assets52.4%
Cash & investments$230.63M
Total debt$682.97M
Net cash (debt)-$452.34M
Free cash flow / sales6.0%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $207.61M | $183.90M | $171.17M | $719.89M | $183.11M |
| Total Operating Revenue | $207.61M | $183.90M | $171.17M | $719.89M | $183.11M |
| Cost of Revenue | $107.98M | $90.43M | $100.85M | $363.83M | $97.44M |
| Gross Profit | $99.63M | $93.47M | $70.32M | $356.06M | $85.67M |
| Operating Expense | $48.86M | $53.74M | $56.69M | $215.65M | $50.06M |
| Selling and Admin Expenses | $28.78M | $31.58M | $29.96M | $129.81M | $26.75M |
| -Selling & Marketing Expense | $11.93M | $13.34M | $11.93M | $43.89M | $10.28M |
| -General & Admin Expense | $16.84M | $18.24M | $18.03M | $85.93M | $16.47M |
| Research & Development | $20.08M | $22.16M | $26.74M | $85.84M | $23.31M |
| Operating Profit | $50.77M | $39.73M | $13.63M | $140.40M | $35.61M |
| Net Non-Operating Interest Income (Expense) | -$4.47M | -$4.37M | -$4.15M | -$16.80M | -$4.21M |
| Non-Operating Interest Income | $2.29M | $2.29M | $2.40M | $8.68M | $2.42M |
| Non-Operating Interest Expense | $6.76M | $6.66M | $6.55M | $25.48M | $6.63M |
| Other Income (Expense) | $2.76M | $3.19M | $575,000.00 | $23,000.00 | $515,000.00 |
| Other Non-Operating Income (Expenses) | $2.76M | $3.19M | $575,000.00 | $23,000.00 | $515,000.00 |
| Pretax Profit | $49.06M | $38.54M | $10.05M | $123.62M | $31.91M |
| Tax | $11.30M | $8.20M | $3.63M | $25.53M | $7.49M |
| Net Profit | $37.76M | $30.35M | $6.42M | $98.09M | $24.43M |
| Profit from Continuing Operations | $37.76M | $30.35M | $6.42M | $98.09M | $24.43M |
| Net Income to Parent Company | $37.76M | $30.35M | $6.42M | $98.09M | $24.43M |
| Net Income to Common Stockholders | $37.76M | $30.35M | $6.42M | $98.09M | $24.43M |
| Basic EPS | $0.89 | $0.69 | $0.14 | $2.10 | $0.53 |
| Diluted EPS | $0.87 | $0.67 | $0.14 | $2.03 | $0.51 |
| – | – | – | $0.00 | – | |
| Earnings from Equity Interest Net of Tax | – | – | – | – | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.71B | $1.74B | $1.65B | $1.63B | $1.63B |
| Total Current Assets | $602.69M | $630.95M | $633.68M | $636.02M | $636.02M |
| Cash and Cash Equivalents & Short-Term Investments | $230.63M | $290.12M | $291.95M | $282.81M | $282.81M |
| -Cash and Cash Equivalents | $204.59M | $223.61M | $170.94M | $170.18M | $170.18M |
| -Short Term Investments | $26.05M | $66.51M | $121.01M | $112.64M | $112.64M |
| Receivables | $184.75M | $147.49M | $157.45M | $160.73M | $160.73M |
| -Accounts Receivable | $182.22M | $144.86M | $147.85M | $143.56M | $143.56M |
| -Taxes Receivable | $2.53M | $2.63M | $9.61M | $17.17M | $17.17M |
| Inventory | $173.92M | $179.91M | $170.19M | $176.89M | $176.89M |
| Restricted Cash | $2.44M | $2.44M | $2.44M | $2.44M | $2.44M |
| Other Current Assets | $10.95M | $11.00M | $11.65M | $13.15M | $13.15M |
| Total Non-Current Assets | $1.11B | $1.11B | $1.01B | $993.28M | $993.28M |
| Net PPE | $388.05M | $389.13M | $378.91M | $353.72M | $353.72M |
| -Gross PPE | $717.24M | $710.35M | $692.28M | $659.99M | $659.99M |
| -Accumulated Depreciation | -$329.20M | -$321.22M | -$313.37M | -$306.27M | -$306.27M |
| Goodwill and Other Intangible Assets | $640.43M | $647.83M | $559.62M | $565.97M | $565.97M |
| -Goodwill | $3.30M | $3.31M | $3.33M | $3.40M | $3.40M |
| -Other Intangible Assets | $637.13M | $644.52M | $556.29M | $562.56M | $562.56M |
| Non-Current Deferred Assets | $42.46M | $42.46M | $42.46M | $42.46M | $42.46M |
| Other Non-Current Assets | $38.10M | $33.39M | $33.48M | $31.14M | $31.14M |
| Total Liabilities | $897.17M | $975.61M | $874.77M | $840.49M | $840.49M |
| Total Current Liabilities | $181.43M | $263.21M | $164.48M | $158.16M | $158.16M |
| Payables | $36.62M | $29.47M | $35.91M | $32.83M | $32.83M |
| -Accounts Payable | $34.48M | $28.93M | $35.50M | $32.59M | $32.59M |
| -Total Tax Payable | $2.14M | $546,000.00 | $414,000.00 | $239,000.00 | $239,000.00 |
| Current Accrued Expenses | $133.59M | $222.44M | $117.19M | $115.76M | $115.76M |
| Short-Term Debt and Capital Lease Obligation | $11.22M | $11.29M | $11.38M | $9.57M | $9.57M |
| -Current Debt | $2.51M | $2.49M | $1.67M | $1.64M | $1.64M |
| -Current Capital Lease Obligation | $8.72M | $8.80M | $9.71M | $7.93M | $7.93M |
| Total Non-Current Liabilities | $715.74M | $712.40M | $710.29M | $682.34M | $682.34M |
| Long Term Debt and Capital Lease Obligation | $680.47M | $677.03M | $675.00M | $646.43M | $646.43M |
| -Long Term Debt | $610.50M | $609.56M | $609.80M | $608.75M | $608.75M |
| -Long Term Capital Lease Obligation | $69.97M | $67.47M | $65.20M | $37.68M | $37.68M |
| Non-Current Deferred Liabilities | $5.93M | $5.93M | $5.93M | $5.93M | $5.93M |
| Other Non-Current Liabilities | $29.34M | $29.44M | $29.37M | $29.98M | $29.98M |
| Total Equity | $814.55M | $768.16M | $773.39M | $788.81M | $788.81M |
| Stockholders' Equity | $814.55M | $768.16M | $773.39M | $788.81M | $788.81M |
| Capital Stock | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -Common Stock | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $562.15M | $553.00M | $543.82M | $535.38M | $535.38M |
| Retained Earnings | $741.41M | $703.65M | $673.30M | $666.88M | $666.88M |
| Less: Treasury Stock | -$482.99M | -$482.60M | -$438.00M | -$408.15M | -$408.15M |
| Gains/Losses Not Affecting Retained Earnings | -$6.02M | -$5.90M | -$5.74M | -$5.31M | -$5.31M |
| Investments and Advances | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $43.30M | $51.32M | $47.84M | $156.12M | $32.86M |
| Net cash flow from continuing operations | $43.30M | $51.32M | $47.84M | $156.12M | $32.86M |
| Net Income from Continuing Operations | $37.76M | $30.35M | $6.42M | $98.09M | $24.43M |
| Gain/Loss from Continuing Operations | -$2.27M | -$870,000.00 | -$412,000.00 | $2.53M | $477,000.00 |
| Depreciation & Depletion & Amortization | $17.74M | $16.46M | $16.49M | $63.20M | $15.99M |
| Other Non-Cash Items | $974,000.00 | $875,000.00 | $761,000.00 | $3.36M | $866,000.00 |
| Change in Working Capital | -$17.92M | -$2.58M | $15.31M | -$65.97M | -$42.73M |
| -Change in Receivables | -$37.39M | $2.98M | -$4.55M | -$6.37M | $3.23M |
| -Change in Inventory | $5.92M | -$9.88M | $6.25M | -$21.06M | $9.01M |
| -Change in Prepaid Assets | -$2.11M | -$2.54M | -$2.33M | -$3.53M | $9.83M |
| -Change in Payables and Accrued Expense | $15.86M | $1.96M | $9.60M | -$4.56M | -$42.64M |
| -Change in Other Current Liabilities | -$1.89M | -$2.20M | -$1.42M | -$5.61M | -$1.66M |
| -Change In Other Working Capital | $1.69M | $7.11M | $7.74M | -$24.84M | -$20.50M |
| Net cash flow from investing | -$63.96M | $44.87M | -$16.73M | -$70.33M | -$60.57M |
| Net Cash Flow from Continuing Investing Activities | -$63.96M | $44.87M | -$16.73M | -$70.33M | -$60.57M |
| Net PPE Purchase and Sale | -$9.94M | -$8.59M | -$9.51M | -$34.88M | -$8.27M |
| Net Intangibles Purchase and Sale | -$94.50M | – | – | -$2.25M | $0.00 |
| Net Investment Purchase and Sale | $40.82M | $55.26M | -$7.23M | -$28.84M | -$51.86M |
| Net Other Investing Changes | -$338,000.00 | – | – | -$4.36M | -$434,000.00 |
| Financing Cash Flow | $1.71M | -$43.54M | -$30.21M | -$67.43M | -$18.37M |
| Net Cash Flow from Continuing Financing Activities | $1.71M | -$43.54M | -$30.21M | -$67.43M | -$18.37M |
| Net Issuance Payments Of Debt | -$33,000.00 | -$525,000.00 | -$29,000.00 | $5.99M | $169,000.00 |
| Net Common Stock Issuance | -$438,000.00 | -$45.21M | -$29.49M | -$75.59M | -$20.52M |
| Proceeds from Stock Option Exercised | $2.18M | $2.20M | -$686,000.00 | $2.86M | $1.98M |
| Ending Cash Balance | $204.82M | $223.85M | $171.17M | $170.41M | $170.41M |
| Net Change in Cash | -$18.95M | $52.66M | $900,000.00 | $18.36M | -$46.08M |
| Beginning Cash Balance | $223.85M | $171.17M | $170.41M | $151.84M | $216.50M |
| Effect of Exchange Rate Changes | -$72,000.00 | $16,000.00 | -$138,000.00 | $210,000.00 | -$9,000.00 |
| Free Cash Flow | -$61.14M | $42.73M | $38.33M | $118.98M | $24.59M |
| Deferred Tax | – | – | – | $27.63M | – |
| Net Business Purchase and Sale | – | – | – | $0.00 | $0.00 |
| Net Other Financing Charges | – | – | – | -$687,000.00 | -$8,000.00 |
No comments yet — be the first to weigh in on AMPH.
Sign in to join the discussion.